Lindsey Saxon July 17, 2024 FDA grants approval to DiscGenics for Phase III trial of cell therapy Lindsey Saxon July 17, 2024 Clinical Trials Arena
Lindsey Saxon July 9, 2024 Discgenics’ cell therapy on phase III track for disc degeneration Lindsey Saxon July 9, 2024 BioWorld
Lindsey Saxon March 25, 2024 Noninvasive Injectables for Chronic Low Back Pain Lindsey Saxon March 25, 2024 IEEE Pulse
Daniel Ashton September 5, 2023 A Revolutionary Approach to Treating Degenerative Disc Disease: Merge Medical Podcast with DiscGenics Daniel Ashton September 5, 2023 Merge Medical Podcast
caleb kingston July 17, 2023 A New Era in Spinal Care: FORCE Family Office Fireside Chat with DiscGenics and Piper Sandler caleb kingston July 17, 2023 FORCE Family Office Webinar
caleb kingston May 3, 2023 Force Family Office Fireside Chat: Expert Panel Discusses DiscGenics’ Potential Cure for Degenerative Disc Disease caleb kingston May 3, 2023 FORCE Family Office Webinar
Lindsey Saxon April 13, 2023 Achieving Regeneration in Lumbar Degenerative Disc Disease Lindsey Saxon April 13, 2023 CGTLive
Lindsey Saxon February 27, 2023 High-dose allogeneic disc progenitor cells may improve low back pain Lindsey Saxon February 27, 2023 Orthopedics Today
Lindsey Saxon February 7, 2023 DiscGenics receives FDA RMAT designation for IDCT for degenerative disc disease Lindsey Saxon February 7, 2023 Spinal News International
Lindsey Saxon January 26, 2023 Discogenic Progenitor Cell Therapy Shows Improvements in Lumbar Degenerative Disc Disease, Recognized by FDA Lindsey Saxon January 26, 2023 CGTLive
Lindsey Saxon February 28, 2022 DiscGenics reports positive Phase I/II data from degenerative disc disease trial Lindsey Saxon February 28, 2022 Clinical Trials Arena
Lindsey Saxon February 28, 2022 DiscGenics Touts Positive Clinical Data for DDD Cell Therapy Lindsey Saxon February 28, 2022 Orthopedic Design & Technology
Lindsey Saxon February 9, 2021 DiscGenics completes construction on Salt Lake City HQ — 7 things to know Lindsey Saxon February 9, 2021 Becker’s Spine Review
Lindsey Saxon October 22, 2020 DiscGenics Raises $50 Million For its Novel Back Pain Treatment Lindsey Saxon October 22, 2020 TechBuzz News
Lindsey Saxon September 18, 2020 Living Progenitor Cells Edge Closer to "Cure-All" Status Lindsey Saxon September 18, 2020 Orthopedics This Week
Lindsey Saxon September 9, 2020 Former Medtronic Spine and Biologics exec appointed DiscGenics CFO Lindsey Saxon September 9, 2020 Becker’s Spine Review
Lindsey Saxon August 27, 2020 DiscGenics Raises $50M in Series C Funding Lindsey Saxon August 27, 2020 FinSMEs
Lindsey Saxon June 22, 2020 Alleviating chronic back pain: an interview with Isaac Erickson Lindsey Saxon June 22, 2020 RegMedNet
Lindsey Saxon March 4, 2020 DiscGenics Announces Completion of Enrollment in U.S. Phase 1/2 Clinical Trial of Discogenic Cell Therapy for Degenerative Disc Disease Lindsey Saxon March 4, 2020 OrthoSpineNews
Lindsey Saxon February 26, 2020 Why Cell-Based Therapies Could Be an Alternative to Opioids Lindsey Saxon February 26, 2020 Future of Personal Health
